Rice bran modulates renal disease risk factors in animals submitted to high sugar-fat diet

Abstract

Introduction:

Obesity, diabetes, and hypertension are common risk factors for chronic kidney disease (CKD). CKD arises due to many pathological insults, including inflammation and oxidative stress, which affect renal function and destroy nephrons. Rice bran (RB) is rich in vitamins and minerals, and contains significant amount of antioxidants. The aim of this study was to evaluate the preventive effect of RB on renal disease risk factors.

Methods:

Male Wistar rats (±325 g) were divided into two experimental groups to received a high sugar-fat diet (HSF, n = 8) or high sugar-fat diet with rice bran (HSF + RB, n = 8) for 20 weeks. At the end, renal function, body composition, metabolic parameters, renal inflammatory and oxidative stress markers were analyzed.

Results:

RB prevented obesity [AI (HSF= 9.92 ± 1.19 vs HSF + RB= 6.62 ± 0.78)], insulin resistance [HOMA (HSF= 83 ± 8 vs. HSF + RB= 42 ± 11)], dyslipidemia [TG (HSF= 167 ± 41 vs. HSF + RB=92 ± 40)], inflammation [TNF-α (HSF= 80 ± 12 vs. HSF + RB=57 ± 14), IL-6 (903 ± 274 vs. HSF + RB=535 ± 277)], oxidative stress [protein carbonylation (HSF= 3.38 ± 0.18 vs. HSF + RB=2.68 ± 0.29), RAGE (HSF=702 ± 36 vs. RSF + RB=570 ± 190)], and renal disease [protein/creatinine ratio (HSF=1.10 ± 0.38 vs. HSF + RB=0.49 ± 0.16)].

Conclusion:

In conclusion, rice bran prevented renal disease by modulating risk factors.

Keywords:
Kidney Function Tests; Phytochemicals; Inflammation; Oxidative Stress

Resumo

Introdução:

Obesidade, diabetes e hipertensão arterial são fatores de risco comuns para doenças renais crônicas (DRC). A DRC surge devido a muitos insultos patológicos, incluindo inflamação e estresse oxidativo, que afetam a função renal e destroem os néfrons. O farelo de arroz (FA) é rico em vitaminas e minerais, e contém uma quantidade significativa de antioxidantes. O objetivo deste estudo foi avaliar o efeito preventivo do FA nos fatores de risco de doenças renais.

Métodos:

Ratos Wistar machos (±325 g) foram divididos em dois grupos experimentais para receber uma dieta rica em gordura e açúcar (DRGA, n = 8) ou uma dieta rica em gordura e açúcar com farelo de arroz (DRGA + FA, n = 8) por 20 semanas. Ao final, foram analisados a função renal, composição corporal, parâmetros metabólicos, marcadores renais inflamatórios e de estresse oxidativo.

Resultados:

FA preveniu a obesidade [IA (DRGA= 9,92 ± 1,19 vs. DRGA + FA= 6,62 ± 0. 78)], resistência à insulina [HOMA (DRGA= 83 ± 8 vs DRGA + FA= 42 ± 11)], dislipidemia [TG (DRGA= 167 ± 41 vs. DRGA + FA=92 ± 40)], inflamação [FNT-α (DRGA= 80 ± 12 vs. DRGA + FA=57 ± 14), IL-6 (903 ± 274 vs. DRGA + FA= 535 ± 277)], estresse oxidativo [carbonilação de proteína (DRGA= 3. 38 ± 0,18 vs. DRGA + FA=2,68 ± 0,29), RAGE (DRGA=702 ± 36 vs. DRGA + FA=570 ± 190)], e doença renal [relação proteína/creatinina (DRGA=1,10 ± 0,38 vs. DRGA + FA=0,49 ± 0,16)].

Conclusão:

Em conclusão, o farelo de arroz preveniu doenças renais através da modulação dos fatores de risco.

Descritores:
Testes de Função Renal; Compostos Fitoquímicos; Inflamação; Estresse Oxidativo

Introduction

Chronic kidney disease (CKD) is defined as changes in the kidney function or structure for more than three months, independent of the cause, which affect the health of an individual¹. Epidemiological data show that CKD affects 10-16% of adults in the world², being considered a global health problem. CKD diagnosis is usually established by the glomerular filtration rate (GFR). However, the reference GFR range does not exclude renal disease, since renal disease leads to decrease of renal function. Within this context, the National Kidney Foundation recommends proteinuria analysis for early stage detection and GFR estimations for assessing the progression of kidney disease³.

Obesity, diabetes, and hypertension are common risk factors for CKD⁴. CKD arises due to many pathological insults, including inflammation and oxidative stress, which affect the renal function and destroy nephrons. The literature reports an association between renal impairment and different mediators of inflammation including interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) suggesting that CKD is a low-grade inflammatory process^5,6.

Oxidative stress can be considered an imbalance in the reactive oxygen species (ROS) production/degradation ratio. Excessive ROS levels can produce cellular damage by interacting with biomolecules (proteins, lipids, and nucleic acids) resulting in negative effects on tissue function and structure, including kidney. Studies show that increased oxidative stress markers, as malondialdehyde (MDA) and carbonylated protein are inversely correlated with kidney function^5,7. As a result, the nephrons compensate the function of injured nephrons with hyperfiltration, leading to glomerular hypertension, proteinuria, and eventually loss of renal function overt time¹.

Several mechanisms are associated with renal inflammation and oxidative stress. When activated, the receptor for advanced glycation end products (RAGE), a multi-ligand member of the immunoglobulin superfamily of cell surface receptors, leads to a signalling sequence with the activation of the nuclear factor kappa-B (NFκB) resulting in proinflammatory cytokines production, such as TNF-α, IL-6, and monocyte chemoattractant protein-1 (MCP-1)⁸. RAGE activation can also directly induce oxidative stress by activating nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase (NOX), especially NOX-4. Thus, RAGE activation is an interface between oxidative stress and inflammation, which are pillars for development of several diseases, especially in organs that express these AGE receptors, as brain, heart, and kidneys⁹.

In this context, an interest has emerged on the role of functional foods to prevent some diseases. Rice bran is one of the most abundant products produced in the rice milling industry that is rich in vitamins, including vitamin E, thiamin, niacin, and minerals like aluminum, calcium, chlorine, iron, magnesium, manganese, phosphorus, potassium, sodium, and zinc. It also contains a significant amount of antioxidants such as tocopherols, tocotrienols, and oryzanol. Rice bran also has proteins of high nutritional value and it is a good source of both soluble and insoluble dietary fiber¹⁰. Thus, considering that the consumption of high sugar-fat diet can lead to obesity and kidney disease risk factors development and the lack of studies regarding the effect of rice bran on these physiopathological aspects, the aim of this study was to evaluate the effect of rice bran on the modulation of renal disease risk factors in animals submitted to high sugar-fat diet.

Material and methods

Animals and experimental protocol

In the present study, male Wistar rats (±325 g) from the Animal Center of Botucatu Medical School, Sao Paulo State University (UNESP, Botucatu, SP, Brazil), were divided into two experimental groups to receive high sugar-fat diet (HSF, n = 8) or high sugar-fat diet with rice bran (HSF + RB, n = 8) for 20 weeks. The diets and water were provided ad libitum. The diet composition has been described in our previous study¹¹. All the animals were housed in an environmentally controlled room (22±3 ºC, 12 h light-dark cycle and relative humidity of 60±5%). All of the experiments were performed in accordance with the Canadian Council on Animal Care (CCAC)¹² and the procedures were approved by the Animal Ethics Committee of Botucatu Medical School (1305/2019). In order to confirm the effects of high sugar-fat diet on renal risk factors development in the HSF group, male Wistar (n=8, ±325 g, and same age), fed a standard diet, were used as reference group (baseline control group). At the end of the experiment, the animals were euthanized by decapitation after anesthesia with thiopental (120 mg/kg, intraperitoneal injection) and all efforts were made to minimize suffering. Blood from fasted animals was collected in tubes containing EDTA and centrifuged at 3500 rpm and the plasma was collected for analysis. Fat deposits and kidneys were collected for analysis.

Rice bran dose

Since rice bran contains antinutritionals components, such as lipases and trypsin inhibitors¹⁰, it was subjected to a stabilization process, which consisted of heating in an oven to 100ºC, for 4 minutes. After the stabilization process, it was mixed to the chow in a dose of 11% (w/w). The dose has been chosen based on previous studies¹³.

Nutritional parameters

The nutritional parameters evaluated were: chow intake, water intake, and caloric intake. Caloric intake was determined by multiplying the energy value of each diet (g × Kcal) by the daily food consumption plus the calories from water (0.25 × 4 × mL consumed).

Body composition

Body composition was evaluated considering the final body weight (FBW), and adiposity index (AI). After euthanasia, fat tissues (visceral (VAT), epididymal (EAT), and retroperitoneal (RAT)) were used to calculate the AI by the following formula:

$\mathrm{AI}=\mathrm{VAT}+\mathrm{EAT}+\mathrm{RAT}/\mathrm{FBW}\times 100$

¹⁴.

Metabolic analysis

After 8 h fasting, blood was collected and the plasma was used to measure the biochemical parameters. Glucose concentration was determined using a glucometer (Accu-Chek Performa, Roche Diagnostics Brazil Limited) and triglycerides were measured with an automatic enzymatic analyzer system (Chemistry Analyzer BS-200, Mindray Medical International Limited, Shenzhen, China). The insulin level was measured using the enzyme-linked immunosorbent assay (ELISA) method using commercial kits (EMDMillipore Corporation, Billerica, MA, USA). The homeostatic model of insulin resistance (HOMA-IR) was used as an insulin resistance index, calculated according to the formula: HOMA-IR = (fasting glucose (mmol/L) x fasting insulin (µU/mL))/22.5¹⁵.

Systolic blood pressure

Systolic blood pressure (SBP) was assessed in conscious rats by the noninvasive tail-cuff method with a Narco Bio-Systems^® electrosphygmomanometer (International Biomedical, Austin, TX, USA). The animals were kept in a wooden box (50 × 40 cm) between 38 and 40°C for 4-5 minutes to stimulate arterial vasodilation16. After this procedure, a cuff with a pneumatic pulse sensor was attached to the tail of each animal. The cuff was inflated to 200 mmHg pressure and subsequently deflated. The blood pressure values were recorded on a Gould RS 3200 polygraph (Gould Instrumental Valley View, Ohio, USA). The average of three pressure readings was recorded for each animal.

Renal inflammation

Renal tissue (±150 mg) was homogenized (ULTRA-TURRAX^® T 25 basic IKA^® Werke, Staufen, Germany) in 1.0 mL of phosphate-buffered saline (PBS) pH 7.4 in cold solution and centrifuged at 800 g at 4°C for 10 min. The supernatant (100 µL) was used in the analysis. TNF-α and IL-6 levels were measured using the ELISA method with commercial kits from R&D System, Minneapolis, USA. The supernatant (100 µL) was used for analysis, and the results were corrected by the protein amount.

Renal malondialdehyde levels (mda)

MDA level was used to evaluate the lipid peroxidation. Briefly, 250 µL of epididymal adipose tissue supernatant was used plus 750 µL of 10% trichloroacetic acid for precipitation of proteins. Samples were centrifuged (3000 rpm, for 5 minutes; Eppendorf^® Centrifuge 5804-R, Hamburg, Germany) and the supernatant removed. Thiobarbituric acid (TBA) was added 0.67% in ratio (1:1) and the samples heated for 15 minutes at 100°C. MDA reacts with TBA in the 1:2 (MDA:TBA) ratio. After cooling, the reading at 535nm was performed on Spectra Max 190 microplate reader (Molecular Devices^®, Sunnyvale, CA, USA). The MDA concentration was obtained by the molar extinction coefficient (1.56 x 10⁵ M^-1·cm^-1) and the absorbance of the samples and the final result reported in nmol/g protein¹⁷.

Renal protein carbonylation

Carbonylated proteins were measured by an unspecific method that uses DNPH (2,4-dinitrophenylhydrazine derivatizing agent) and photometric detection of any modified protein by carbonylation. Carbonylated protein levels are reported in nmol of DNPH/mg of protein¹⁸.

Rage levels

Renal tissue (±150 mg) was homogenized (ULTRA-TURRAX^® T 25 basic IKA^® Werke, Staufen, Germany) in 1.0 mL of phosphate-buffered saline (PBS) pH 7.4 in cold solution and centrifuged at 800 g at 4°C for 10 min. The supernatant (100 µL) was used in the analysis. RAGE levels were measured with ELISA method using commercial kits from R&D System, Minneapolis, USA. The results were corrected according to the protein amount.

Renal function

At 24 hours, urine was collected from the metabolic cages to measure the excretion of creatinine and the total protein. All analyses were performed with an automatic enzymatic analyzer system (biochemical analyzer BS-200, Mindray, China). The glomerular filtration rate (GFR = (urine creatinine × flux)/plasma creatinine) and proteinuria (protein/creatinine ratio) were also calculated.

Statistical analysis

The data were submitted to Kolmogorov-Smirnov normality test. Parametric variables were compared by Student’s t-test and the results are reported as mean ± standard deviation. Non-parametric variables were compared by Mann-Whitney test and the results are reported as median (interquartile range (25-75)). Pearson correlation was used to assess the association among parameters. Statistical analyses were performed using Sigma Stat for Windows Version 3.5 (Systat Software Inc., San Jose, CA, USA). A p value < 0.05 was considered statistically significant.

Results

Rice bran effect on nutritional parameters

The nutritional parameters are presented in the Figure 1. It is possible to note the chow, water, and caloric intake in the HSF and HSF + RB groups. The HSF + RB showed lower final body weight and adiposity index than the HSF group.

Figure 1.
Nutritional parameters. A, Chow fed (g/day); B, Water intake (mL/day); C, Caloric intake (kcal/day); D, Final body weight (g); E, Adiposity index (%). Comparison by Student’s t-test or Mann-Whitney test, n=8 animals/group. p < 0.05 was considered significant. HSF: high sugar-fat diet; RB: rice bran. NS: not significant.

Rice bran effect on renal cardiometabolic risk factors

Renal cardiometabolic risk factors are presented in the Figure 2. It is possible to verify reduced HOMA-IR and triglycerides in the HSF + RB group compared to HSF. No rice bran effect was observed on systolic blood pressure.

Figure 2.
Renal cardiometabolic risk factors. A, Systolic blood pressure (mmHg); B, HOMA- IR; C, Triglycerides (mg/dL). Comparison by Student’s t-test or Mann-Whitney test, n=8 animals/group. p < 0.05 was considered significant. HSF: high sugar-fat diet; RB: rice bran. NS: not significant.

Rice bran effect on renal inflammation

Kidney inflammation parameters are presented in the Figure 3. Rice bran was effective to reduce inflammation, since the HSF + RB showed lower TNF-α and IL-6 levels compared to HSF.

Figure 3.
Renal inflammation parameters. A, Tumor necrosis factor alpha (TNF-α, pg/g protein); B, Interleukin-6 (IL-6, pg/g protein). Comparison by Student’s t-test or Mann-Whitney test. p < 0.05 was considered significant. NS: not significant.

Rice bran effect on renal oxidative stress

Figure 4 shows the oxidative stress parameters. The group HSF + RB presented lower protein carbonylation and RAGE level compared to the HSF. No difference was observed for the MDA levels.

Figure 4.
Renal oxidative stress parameters. A, Protein carbonylation (nmol/mg protein) B, Malondialdehyde (nmom/mg protein); C, RAGE (pg/g protein). Comparison by Student’s t-test or Mann-Whitney test. p < 0.05 was considered significant. NS: not significant.

Malondialdehyde (nmom/mg protein); C, RAGE (pg/g protein). Comparison by Student’s t-test or Mann-Whitney test. p < 0.05 was considered significant. NS: not significant.

Renal function parameters

Figure 5 presents the renal function parameters. It is possible to verify the proteinuria presence in the HSF group while the HSF + RB was protected. No difference was observed for the glomerular filtration rate between HSF and HSF + RB groups.

Figure 5.
Renal function evaluation. A, Protein/creatinine ratio; B, Glomerular filtration rate (GFR, mL/min). Comparison by Student’s t-test or Mann-Whitney test. p < 0.05 was considered significant. NS: not significant.

Correlation among the parameters

A positive correlation was found between proteinuria and caloric intake, adiposity index, triglycerides, HOMA, and carbonylation. Regarding the GFR, there was a positive correlation with MDA and a negative correlation with TNF-α (Figure 6).

Figure 6.
Pearson correlation among the variables. Red values indicate negative significant difference, gray values indicate non-significant difference, and blue values indicate positive significant correlation.

Discussion

The study aimed to evaluate the effect of rice bran on the modulation of renal damage risk factors. Kidney disease has a major effect on global health, both as a direct cause of morbidity and mortality and as an important risk factor for cardiovascular disease. Moreover, CKD is preventable and treatable and deserves greater attention in global health policy decision making¹⁹. Thus, the discovery of natural products, as rice bran, able to prevent this condition is extremely relevant. In the present study, a beneficial effect of rice bran was observed on the main renal disease risk factors. At the same time, the HSF group showed proteinuria and several risk factors for kidney injury, among them: obesity, dyslipidemia, insulin resistance, inflammation, and oxidative stress⁴.

The literature is scarce of studies with rice bran and CKD. One study published by our research group found that γOz, the main bioactive compound of rice bran, was effective to recover obesity-induced kidney disease after 10 weeks of treatment in Wistar rats²⁰. Another experimental study by Al-Okbi et al.²¹ found that γ-oryzanol (γ-O) and rice bran oil/γ-O mixture (RBO/γ-O) had protective effects on cardiovascular diseases and cardiorenal syndrome, similar to Francisqueti et al.²², which found a protective effect of γOz on cardiorenal metabolic syndrome.

Obesity has been identified as one of the main cause of kidney disease since it is associated with hemodynamic, structural, and histopathological alterations in the kidney, as well as metabolic and biochemical alterations that predispose to kidney disease^23,24. The animals that received rice bran presented the same chow, water, and caloric intake, however lower final body weight and adiposity index than the HSF group. Although the mechanism by which rice bran protects against obesity is not clarified, the literature confirms this antiobesogenic effect and attributes the benefits to dietary fiber, oligosaccharides, hemicelluloses, and non-starchy polysaccharides as well as some water-soluble phytochemicals present in the rice bran²⁵.

Obesity is the main risk factor for the development of chronic diseases, such as type 2 diabetes and cardiovascular diseases, which increases the risk for CKD²⁶. Hyperglycemia increases the non-enzymatic reaction of glucose and other glycating compounds derived both from glucose and from increased fatty acid oxidation, which generates advanced glycation end products in complication-prone cell types, including kidney cells²⁷. The HSF group not only developed obesity but also insulin resistance. However, the animals that received rice bran did not present insulin resistance, which can be explained by the protection against obesity in the HSF + RB group. An excessive adipose tissue is associated with a chronic low-grade inflammation that may explain the development of the obesity-related pathologies, such as type 2 diabetes mellitus^28,29.

Hypertension is a major risk factor for renal disease³⁰. Multiple mechanisms are involved in determination of renal damage in hypertension, such as the renin-angiotensin-aldosterone system (RAAS), oxidative stress, endothelial dysfunction, and inflammation³¹. In the present study, no effect of rice bran was observed on systolic blood pressure. However, the HSF + RB group presented protection against kidney damage, which can be explained by the effect on inflammation and oxidative stress. The main bioactive compound in RB is gamma-oryzanol, which has demonstrated antioxidative and anti-inflammatory effects^25,32 also in kidneys of obese animals²⁰.

The upregulation of pro-inflammatory cytokines, as IL-6 and TNF-α, mediated by AGE/RAGE and NFκB, increase oxidative stress, which leads to local and systemic inflammation, glomerular and tubular lesions, and proteinuria. Among cytokines, TNF-α is known to cause direct cytotoxicity and apoptosis of renal cells^33,34. Oxidized molecules reflect the damage mediated by oxidative stress in cells and tissues, and their measurement can be indicative of oxidative stress in a specific disease, as well as the potential efficacy of clinical treatments. Some of these modifications, as carbonylation, are irreversible and can lead to altered protein expression and activity, resulting in organ impairment³⁵. Confirming the antioxidant and anti-inflammatory effect of rice bran, the HSF + RB animals showed reduced TNF-α, IL-6, RAGE, protein carbonylation, and proteinuria compared to the HSF group.

In summary, rice bran was able to prevent obesity, insulin resistance, dyslipidemia, inflammation, oxidative stress, and renal disease. These findings provide important information about the use of bioactive compounds as alternative therapeutics for preventing renal disease and associated risk factors. However, since the main limitation of this study was not evaluating the pathways involved in the positive effects of rice bran, more studies are necessary. Therefore, we concluded that rice bran was able to prevent renal disease by modulating risk factors.

References

• ¹
  Gajjala PR, Sanati M, Jankowski J. Cellular and molecular mechanisms of chronic kidney disease with diabetes mellitus and cardiovascular diseases as its comorbidities. Front Immunol. 2015;6:340. DOI: https://doi.org/10.3389/fimmu.2015.00340
  » https://doi.org/10.3389/fimmu.2015.00340
• ²
  Kazancioǧlu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl. 2013 Dec;3(4):368-71. DOI: https://doi.org/10.1038/kisup.2013.79
  » https://doi.org/10.1038/kisup.2013.79
• ³
  Regeniter A, Freidank H, Dickenmann M, Boesken WH, Siede WH. Evaluation of proteinuria and GFR to diagnose and classify kidney disease: systematic review and proof of concept. Eur J Intern Med. 2009 Oct;20(6):556-61. DOI: https://doi.org/10.1016/j.ejim.2009.03.006
  » https://doi.org/10.1016/j.ejim.2009.03.006
• ⁴
  Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJL, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013 Jul;382(9889):339-52. DOI: https://doi.org/10.1016/S0140-6736(13)60595-4
  » https://doi.org/10.1016/S0140-6736(13)60595-4
• ⁵
  Cachofeiro V, Goicochea M, Vinuesa SG, Oubĩa P, Lahera V, Lũo J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int. 2008 Dec;74(Suppl 111):S4-S9. DOI: https://doi.org/10.1038/ki.2008.516
  » https://doi.org/10.1038/ki.2008.516
• ⁶
  Landray MJ, Wheeler DC, Lip GYH, Newman DJ, Blann AD, McGlynn FJ, et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) Study. Am J Kidney Dis. 2004;43(2):244-53. DOI: https://doi.org/10.1053/j.ajkd.2003.10.037
  » https://doi.org/10.1053/j.ajkd.2003.10.037
• ⁷
  Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis KP, Tselepis A, et al. Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis. 2006 Nov;48(5):752-60. DOI: https://doi.org/10.1053/j.ajkd.2006.08.015
  » https://doi.org/10.1053/j.ajkd.2006.08.015
• ⁸
  D’Agati V, Schmidt AM. RAGE and the pathogenesis of chronic kidney disease. Nat Rev Nephrol. 2010 Apr;6:352-60. DOI: https://doi.org/10.1038/nrneph.2010.54
  » https://doi.org/10.1038/nrneph.2010.54
• ⁹
  Chaudhuri J, Bains Y, Guha S, Kahn A, Hall D, Bose N, et al. The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality. Cell Metab. 2018 Sep;28(3):337-52. DOI: https://doi.org/10.1016/j.cmet.2018.08.014
  » https://doi.org/10.1016/j.cmet.2018.08.014
• ¹⁰
  Sharif MK, Butt MS, Anjum FM, Khan SH. Rice bran: a novel functional ingredient rice bran. Crit Rev Food Sci Nutr. 2014 Dec;54(6):807-16. DOI: https://doi.org/10.1080/10408398.2011.608586
  » https://doi.org/10.1080/10408398.2011.608586
• ¹¹
  Francisqueti FV, Minatel IO, Ferron AJT, Bazan SGZ, Silva VS, Garcia JL, et al. Effect of gamma-oryzanol as therapeutic agent to prevent cardiorenal metabolic syndrome in animals submitted to high sugar-fat diet. Nutrients. 2017 Dec;9(12):1299.
• ¹²
  Olfert ED, Cross BM, McWilliam AA. Guide to the care and use of experimental animals. Ottawa: Canadian Council on Animal Care (CCAC); 1993. v. 1.
• ¹³
  Kahlon TS, Chow FI, Sayre RN, Betschart AA. Cholesterol-lowering in hamsters fed rice bran at various levels, defatted rice bran and rice bran oil. J Nutr. 1992 Mar;122(3):513-9.
• ¹⁴
  Luvizotto RAM, Nascimento AF, Imaizumi E, Pierine DT, Conde SJ, Correa CR, et al. Lycopene supplementation modulates plasma concentrations and epididymal adipose tissue mRNA of leptin, resistin and IL-6 in diet-induced obese rats. Br J Nutr. 2013 Nov;110(10):1803-9.
• ¹⁵
  Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 Jul;28:412-9. DOI: https://doi.org/10.1007/BF00280883
  » https://doi.org/10.1007/BF00280883
• ¹⁶
  Santos PP, Rafacho BPM, Gonçalves ADF, Jaldin RG, Nascimento TB, Silva MAB, et al. Vitamin D induces increased systolic arterial pressure via vascular reactivity and mechanical properties. PLoS One. 2014 Jun;9(6):e98895.
• ¹⁷
  Samarghandian S, Farkhondeh T, Samini F, Borji A. Protective effects of carvacrol against oxidative stress induced by chronic stress in rat’s brain, liver, and kidney. Biochem Res Int. 2016;2016:2645237.
• ¹⁸
  Mesquita CS, Oliveira R, Bento F, Geraldo D, Rodrigues JV, Marcos JC. Simplified 2,4-dinitrophenylhydrazine spectrophotometric assay for quantification of carbonyls in oxidized proteins. Anal Biochem. 2014 Aug;458:69-71.
• ¹⁹
  GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020 Feb;395(10225):709-33.
• ²⁰
  Francisqueti FV, Ferron AJT, Hasimoto FK, Alves PHR, Garcia JL, Santos KC, et al. Gamma oryzanol treats obesity-induced kidney injuries by modulating the adiponectin receptor 2/PPAR-α axis. Oxid Med Cell Longev. 2018;2018:1278392.
• ²¹
  Al-Okbi SY, Mohamed DA, Hamed TE, Al-Siedy ESK. Rice bran as source of nutraceuticals for management of cardiovascular diseases, cardio-renal syndrome and hepatic cancer. J Herbmed. 2020;9(1):68-74. DOI: https://doi.org/10.15171/jhp.2020.10
  » https://doi.org/10.15171/jhp.2020.10
• ²²
  Francisqueti FV, Minatel IO, Ferron AJT, Bazan SGZ, Silva VS, Garcia JL, et al. Effect of gamma-oryzanol as therapeutic agent to prevent cardiorenal metabolic syndrome in animals submitted to high sugar-fat diet. Nutrients. 2017;9(12):1-10.
• ²³
  Silva Junior GB, Bentes ACSN, Daher EF, Matos SMA. Obesity and kidney disease. J Bras Nefrol. 2017 Mar;39(1):65-9. DOI: https://doi.org/10.5935/0101-2800.20170011
  » https://doi.org/10.5935/0101-2800.20170011
• ²⁴
  Kovesdy CP, Furth S, Zoccali C. Obesity and kidney disease: hidden consequences of the epidemic. Indian J Nephrol. 2017 Mar/Apr;27(2):85-92.
• ²⁵
  Yang SC, Huang WC, Ng XE, Lee MC, Hsu YJ, Huang CC, et al. Rice bran reduces weight gain and modulates lipid metabolism in rats with high-energy-diet-induced obesity. Nutrients. 2019 Sep;11(9):2033.
• ²⁶
  Solini A, Ferrannini E. Pathophysiology, prevention and management of chronic kidney disease in the hypertensive patient with diabetes mellitus. J Clin Hypertens. 2011 Apr;13(4):252-7. DOI: https://doi.org/10.1111/j.1751-7176.2011.00446.x
  » https://doi.org/10.1111/j.1751-7176.2011.00446.x
• ²⁷
  Reidy K, Kang HM, Hostetter T, Susztak K. Molecular mechanisms of diabetic kidney disease. J Clin Invest. 2014 Jun;124(6):2333-40. DOI: https://doi.org/10.1172/JCI72271
  » https://doi.org/10.1172/JCI72271
• ²⁸
  Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013 Mar;7:14-24. DOI: https://doi.org/10.1007/s11684-013-0262-6
  » https://doi.org/10.1007/s11684-013-0262-6
• ²⁹
  Emanuela F, Grazia M, Marco R, Paola LM, Giorgio F, Marco B. Inflammation as a link between obesity and metabolic syndrome. J Nutr Metab. 2012;2012:476380. DOI: https://doi.org/10.1155/2012/476380
  » https://doi.org/10.1155/2012/476380
• ³⁰
  Tedla FM, Brar A, Browne R, Brown C. Hypertension in chronic kidney disease: navigating the evidence. Int J Hypertens. 2011;2011:132405. DOI: https://doi.org/10.4061/2011/132405
  » https://doi.org/10.4061/2011/132405
• ³¹
  Mennuni S, Rubattu S, Pierelli G, Tocci G, Fofi C, Volpe M. Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage. J Hum Hypertens. 2014;28:74-9. DOI: https://doi.org/10.1038/jhh.2013.55
  » https://doi.org/10.1038/jhh.2013.55
• ³²
  Xu Z, Hua N, Godber JS. Antioxidant activity of tocopherols, tocotrienols, and γ -oryzanol components from rice bran against cholesterol oxidation accelerated by 2,2′-azobis (2-methylpropionamidine). J Agric Food Chem. 2001 Apr;49(4):2077-81.
• ³³
  Amorim RG, Guedes GS, Vasconcelos SML, Santos JCF. Kidney disease in diabetes mellitus: cross-linking between hyperglycemia, redox imbalance and inflammation. Arq Bras Cardiol. 2019 May;112(5):577-87. DOI: https://doi.org/10.5935/abc.20190077
  » https://doi.org/10.5935/abc.20190077
• ³⁴
  Mihai S, Codrici E, Popescu ID, Enciu AM, Albulescu L, Necula LG, et al. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J Immunol Res. 2018;2018:2180373. DOI: https://doi.org/10.1155/2018/2180373
  » https://doi.org/10.1155/2018/2180373
• ³⁵
  Vona R, Gambardella L, Cittadini C, Straface E, Pietraforte D. Biomarkers of oxidative stress in metabolic syndrome and associated diseases. Oxid Med Cell Longev. 2019;2019:8267234. DOI: https://doi.org/10.1155/2019/8267234
  » https://doi.org/10.1155/2019/8267234

Publication Dates

• Publication in this collection
  15 Jan 2021
• Date of issue
  Apr-Jun 2021

History

• Received
  04 Aug 2020
• Accepted
  12 Oct 2020